Abbott To Buy St. Jude Medical For $25BAbbott Laboratories will spend $25 billion to buy St. Jude Medical Inc. in a cash-stock deal that aims to strengthen the medical device maker's stake in cardiovascular care.
Despite Drop In 4Q Profits, St. Jude Tops Wall Street Forecasts St. Jude Medical Inc.'s fourth quarter profit fell 54 percent on a mix of lackluster sales and higher expenses, but its adjusted results still beat expectations.
St. Jude Meets 3Q Profit ForecastsSt. Jude Medical Inc. (STJ) on Wednesday reported third-quarter net income of $215 million. On a per-share basis, the St. Paul, Minnesota-based company said it had profit of 75 cents. Earnings, adjusted for one-time gains and costs, came to 97 cents per share.
St. Jude Medical Pays $3.7M To End InvestigationThe U.S. Department of Justice said Thursday that St. Jude Medical Inc. will pay almost $3.7 million to settle allegations it overcharged the government for implantable heart devices.
St. Jude Board Declares Dividend, OKs BuybackMedical device maker St. Jude Medical Inc. said Tuesday its board authorized a share repurchase of up to $300 million and declared a fourth-quarter dividend of 21 cents.
St. Jude Gets European OK For Migraine TreatmentMedical device maker St. Jude Medical Inc. said Wednesday its Genesis implanted nerve stimulation system for treating migraines has been approved for sale in Europe.
St. Jude 1Q Profit Slips On Costs From BuyoutMedical device maker St. Jude Medical Inc. said its first-quarter net income slipped 2 percent, as costs from last year's acquisition of AGA Medical Inc. outweighed revenue gains.
St. Jude Medical Starts Quarterly Cash DividendMedical device maker St. Jude Medical Inc. said Monday its board of directors approved the start of a regular quarterly cash dividend of 21 cents per share.